eBioMedicine, 2026 Multi-omics analysis of the gut microbiome and carotid artery atherosclerosis in men with and without HIV Wang Z., Wang Y., Peters B. et al. Olink Explore 3072/384CVDInfectious DiseasesPathophysiologyPlasma | | | | |
Translational Oncology, 2026 Clinical validation of PEA-driven Olink proteomic discovery: INPP1 and ARHGAP25 serum biomarkers improve early breast cancer diagnosis Huang J., Gao L., Glazutdinova L. et al. Olink Explore 3072/384OncologyPatient StratificationSerum | | | | |
Journal of Clinical & Translational Endocrinology, 2026 Increased cytokine production capacity and persistent inflammation after achieving remission of Cushing’s syndrome van Houten P., van de Ven A., van Herwaarden A. et al. Olink Target 96EndocrinologyPathophysiologyPlasma | | | | |
npj Digital Medicine, 2026 Leveraging population-scale proteomic data with deep learning for head and neck cancer detection in saliva Shakeel A., Merriel S., Smith J. et al. Olink Target 96Olink Explore 3072/384OncologyWider Bioinformatics StudiesTechnical EvaluationData SciencePlasmaSaliva | | | | |
ERJ Open Research, 2026 Proteome-wide Mendelian randomisation of lung function to identify potential therapeutic targets for respiratory disease Chen J., Shrine N., Coley K. et al. Olink Explore 3072/384Respiratory DiseasesPathophysiologyPlasma | | | | |
Blood Cancer Journal, 2026 A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients Firestone R., Simhal A., Akhlaghi T. et al. Olink Target 96OncologyPatient StratificationPlasma | | | | |
Atherosclerosis, 2026 Inflammation may explain part of atherosclerotic cardiovascular disease risk conferred by elevated remnant lipoproteins: a cohort and Mendelian randomization study Wadström B., Wulff A., Pedersen K. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
JHEP Reports, 2026 Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B Holmberg M., Niehrs A., Dalgard O. et al. Olink Target 96HepatologyPathophysiologySerum | | | | |
eBioMedicine, 2026 A randomized, observer-blind, phase 1 study of immune responses to three human adenovirus type 26 vector–based vaccines Hertoghs N., Serroyen J., Tolboom J. et al. Olink Explore 3072/384Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Archives of Medical Science, 2026 Deciphering the Interplay Between Inflammatory Factors and Brain Structural Features in Epilepsy Fang S., Dong X., Li X. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Neurobiology of Disease, 2026 Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson's disease severity Jin H., Meng L., Yulug B. et al. Olink Explore 3072/384NeurologyPatient StratificationPlasma | | | | |
Neurobiology of Disease, 2026 A NETs-centric multi-omics framework prioritizes PGLYRP1 and MMP9 as subtype-associated thromboinflammatory biomarker candidates and putative therapeutic hypotheses in ischemic stroke Tan H., Gong H., Li H. et al. Olink Target 96CVDNeurologyPathophysiologyPlasma | | | | |
Lung Cancer, 2026 A dynamic proteomic signature for the prediction of lung Cancer: a longitudinal analysis in the UK Biobank cohort Liang J., Feng Y., Gui D. et al. Olink Explore 3072/384OncologyPathophysiologyPatient StratificationPlasma | | | | |
Journal of Infection, 2026 Early antiretroviral therapy shapes the immunometabolic landscape without reducing the intact HIV reservoir Suanzes P., Grau-Expósito J., Navarro J. et al. Olink Target 48Infectious DiseasesPathophysiologyPlasma | | | | |
Nature Biotechnology, 2026 mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression Marks A., Siu S., Bianchini F. et al. Olink Target 96 MouseImmunological & Inflammatory DiseasesPathophysiologyMouse Cell Culture Supernatant | | | | |
Nature Genetics, 2026 Multi-ancestry genome-wide association and integrated multi-omics analyses of endometriosis and its clinical manifestations Koller D., He J., Løkhammer S. et al. Olink Explore 3072/384GynecologyPathophysiologyPlasma | | | | |
Nature Medicine, 2026 Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial Li H., Xu Y., Chen Y. et al. Olink Target 96HematologyPathophysiologyPlasma | | | | |
BMC Medicine, 2026 Adherence to the EAT-Lancet Diet, plasma proteomics, and risk of venous thromboembolism: a large-scale prospective cohort study He Q., Sun M., Wang Y. et al. Olink Explore 3072/384CVDNutritional SciencePathophysiologyPlasma | | | | |
Urogenital Tract Infection, 2026 Identification of Plasma Biomarker Signatures for Acute and Chronic Cystitis Using Olink Explore Proteomics in UK Biobank Kang C., Kim S. Olink Explore 3072/384UrologyPatient StratificationPlasma | | | | |
BioData Mining, 2026 Divide-and-conquer analysis reveals hidden immune cell influencers across the placenta in preeclampsia Paik H., Ko T., Park M. et al. Olink Target 96Olink Target 48ObstetricsPathophysiologyPlasmaUrine | | | | |